If you have diabetes, cardiovascular disease, gastrointestinal disorders, or take medications affecting absorption, request a comprehensive clinical review before starting
requires medical supervision Administration Method Both GLP-1 and GLP-2 analogs are typically administered via subcutaneous injection (under the skin), similar to insulin
In patients with T2D, the most common adverse events, other than hypoglycemia, were GI, including nausea (30%) and vomiting (7%)
Not everyone will need full-dose GLP-1 therapy, but microdosing could provide enough benefit to improve metabolic health, reduce inflammation, or modulate immune function
The results highlight a potentially differentiated profile combining substantial weight loss, favorable tolerability, and a dual formulation strategy
Some medications may be eligible for reimbursement through Health Savings Accounts (HSAs) or Flexible Spending Accounts (FSAs)